Isabelle Staropoli

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications

Complement augments antibody neutralization of SARS-CoV-2 variants.

Complement augments antibody neutralization of SARS-CoV-2 variants.

Journal: Science translational medicine
Published: July 22, 2026

Temperature-dependent replication and sensitivity to innate immunity of human coronavirus HKU1.

Temperature-dependent replication and sensitivity to innate immunity of human coronavirus HKU1.

Journal: Nature communications
Published: November 07, 2025

Immunogenicity of single-chain antibodies: germlining of a VHH lowers T-cell activation from epitopes in FR2 and CDR regions.

Immunogenicity of single-chain antibodies: germlining of a VHH lowers T-cell activation from epitopes in FR2 and CDR regions.

Journal: mAbs
Published: October 13, 2025

Immunogenicity and protective efficacy on non-adjuvanted CD40-targeting SARS-CoV-2 vaccines in non-human primates.

Immunogenicity and protective efficacy on non-adjuvanted CD40-targeting SARS-CoV-2 vaccines in non-human primates.

Journal: EBioMedicine
Published: September 10, 2025

Impaired serum neutralization and death in Omicron-infected critically ill patients: insights from the French SEVARVIR prospective, multicenter cohort study.

Impaired serum neutralization and death in Omicron-infected critically ill patients: insights from the French SEVARVIR prospective, multicenter cohort study.

Journal: Intensive care medicine experimental
Published: June 27, 2025

Household exposure, demographic and health characteristics associated with SARS-CoV-2 infection in a cohort study in Northern France.

Household exposure, demographic and health characteristics associated with SARS-CoV-2 infection in a cohort study in Northern France.

Journal: Scientific reports
Published: May 29, 2025

Escape of SARS-CoV-2 Variants KP.1.1, LB.1, and KP3.3 From Approved Monoclonal Antibodies.

Escape of SARS-CoV-2 Variants KP.1.1, LB.1, and KP3.3 From Approved Monoclonal Antibodies.

Journal: Pathogens & immunity
Published: August 20, 2024

In Vitro and In Vivo Neutralizing Efficacy of Monoclonal Antibodies Against Sars-Cov-2 Variants in Kidney Transplant Recipients.

In Vitro and In Vivo Neutralizing Efficacy of Monoclonal Antibodies Against Sars-Cov-2 Variants in Kidney Transplant Recipients.

Journal: Transplant international : official journal of the European Society for Organ Transplantation
Published: May 18, 2024

Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2.

Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2.

Journal: iScience
Published: April 25, 2024

Modeling memory B cell responses in a lymphoid organ-chip to evaluate mRNA vaccine boosting.

Modeling memory B cell responses in a lymphoid organ-chip to evaluate mRNA vaccine boosting.

Journal: The Journal of experimental medicine
Published: February 14, 2024

Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion.

Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion.

Journal: Nature communications
Published: December 14, 2023

High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1.

High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1.

Journal: Journal of virology
Published: December 13, 2023
Showing 1-12 of 55

Last Updated: 09/26/2026